| Dr Kamran Torbati, MD | |
|
5525 Etiwanda Ave, #216, Tarzana, CA 91356-3647 | |
| (818) 344-0300 | |
| (818) 344-0370 |
| Full Name | Dr Kamran Torbati |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 38 Years |
| Location | 5525 Etiwanda Ave, Tarzana, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639183056 | NPI | - | NPPES |
| 00A48821 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | A48821 (California) | Primary |
| Entity Name | Kamran Torbati Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952533259 PECOS PAC ID: 5395890651 Enrollment ID: O20090910000147 |
News Archive
ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) clearance of CarriGen® Porous Bone Substitute Material. CarriGen is available for immediate sale through ETEX's independent sales force. CarriGen builds upon the clinically proven benefit of ETEX nanocrystalline calcium phosphate technology by adding the advantage of increased porosity and pore size. CarriGen is the first highly porous bone graft substitute that sets hard upon implantation for a complete defect fill.
Crohn's disease, a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years.
Medical Staffing Network Holdings, Inc. (OTCQX: MSNW) announced today that its Board of Directors has adopted a stockholder rights plan designed to deter coercive takeover tactics, including the accumulation of shares in the open market or through private transactions and to prevent an acquiror from gaining control of the Company without offering a fair price to all of the Company's stockholders.
In an age of increased integration between physicians and hospitals, regulators should continue to scrutinize proposed hospital mergers and take steps to maintain competition, according to a new paper by experts at Rice University's Baker Institute for Public Policy.
An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kamran Torbati, MD Po Box 260978, Encino, CA 91426-0978 Ph: (818) 344-0300 | Dr Kamran Torbati, MD 5525 Etiwanda Ave, #216, Tarzana, CA 91356-3647 Ph: (818) 344-0300 |
News Archive
ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) clearance of CarriGen® Porous Bone Substitute Material. CarriGen is available for immediate sale through ETEX's independent sales force. CarriGen builds upon the clinically proven benefit of ETEX nanocrystalline calcium phosphate technology by adding the advantage of increased porosity and pore size. CarriGen is the first highly porous bone graft substitute that sets hard upon implantation for a complete defect fill.
Crohn's disease, a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years.
Medical Staffing Network Holdings, Inc. (OTCQX: MSNW) announced today that its Board of Directors has adopted a stockholder rights plan designed to deter coercive takeover tactics, including the accumulation of shares in the open market or through private transactions and to prevent an acquiror from gaining control of the Company without offering a fair price to all of the Company's stockholders.
In an age of increased integration between physicians and hospitals, regulators should continue to scrutinize proposed hospital mergers and take steps to maintain competition, according to a new paper by experts at Rice University's Baker Institute for Public Policy.
An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center.
› Verified 9 days ago
Dr. Dennis L Perlow, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5525 Etiwanda Ave, Suite 209, Tarzana, CA 91356 Phone: 818-344-8822 Fax: 818-344-3587 | |
Dr. Honey Milestone, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 18372 Clark St Ste 203, Tarzana, CA 91356 Phone: 310-866-0049 Fax: 818-206-1408 | |
Dr. James Albert Danielzadeh, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 18370 Burbank Blvd, Suite 209, Tarzana, CA 91356 Phone: 818-881-5661 | |
Dr. Roy Daniel Ayalon, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 18411 Clark St Ste 107, Tarzana, CA 91356 Phone: 818-654-9312 | |
Dr. Vuk Jovanovic, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 18370 Burbank Blvd Ste 511, Tarzana, CA 91356 Phone: 818-344-8522 Fax: 310-579-6576 | |
Brian Keith Fenmore, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 18344 Clark St, Suite 202, Tarzana, CA 91356 Phone: 818-708-8011 Fax: 818-708-8826 | |
Tina Buerano Verder, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 18411 Clark St, Suite 102, Tarzana, CA 91356 Phone: 877-503-0518 Fax: 877-503-0520 |